Revelation Biosciences, Inc.
REVB
$3.08
$0.082.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.80% | -53.26% | -23.16% | -17.80% | 128.28% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.25% | -22.80% | -49.72% | -78.37% | 15.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -18.46% |
| Total Current Assets | -45.95% | -52.93% | -23.57% | -18.92% | 124.40% |
|
|
|||||
| Total Current Assets | -45.95% | -52.93% | -23.57% | -18.92% | 124.40% |
| Net Property, Plant & Equipment | -13.52% | 13.88% | -8.76% | -7.03% | -27.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -45.78% | -52.60% | -23.50% | -18.86% | 121.91% |
|
|
|||||
| Total Accounts Payable | -42.38% | 148.75% | 40.20% | 138.51% | 145.38% |
| Total Accrued Expenses | -2.14% | -8.57% | 1,601.37% | -36.31% | 16.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -99.93% | -99.85% | -56.63% | -54.43% | 4.85% |
| Total Other Current Liabilities | -99.93% | -99.85% | -56.63% | -54.43% | 4.85% |
| Total Current Liabilities | -65.61% | -24.69% | 140.68% | -35.46% | 25.03% |
|
|
|||||
| Total Current Liabilities | -65.61% | -24.69% | 140.68% | -35.46% | 25.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -65.61% | -24.69% | 140.68% | -35.46% | 25.03% |
|
|
|||||
| Common Stock & APIC | 40.79% | 29.21% | 17.56% | 28.82% | 21.65% |
| Retained Earnings | -59.05% | -66.69% | -77.06% | -46.70% | -0.47% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -29.17% | -69.68% | -90.01% | -5.44% | 531.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.17% | -69.68% | -90.01% | -5.44% | 531.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.17% | -69.68% | -90.01% | -5.44% | 531.61% |
|
|
|||||